Bot Chart, page-13861

Let's look at the weekly:



The far left of the screen is Jan 2023. ..

On the weekly timeframe, we could be heading into a longer basing period like we did directly after Sofdra was knocked backed with labelling issues, or it could just be a little 'step' like the 2 preceding FDA approval (see the purple boxes).

---
Drilling right down into 2 minute chart:


That thick maroon line is the VWAP (volume weighted average price) since FDA approval. So it's trading below VWAP right now suggesting it's selling at 'below market rates'. A bargain perhaps?

---

Not a tonne of analysis here. Just wanted to contrast the weekly to the short term and say that individual days like today aren't pivotal in the long term trend.

IMO the fundamentals are strong and the technicals aren't bad here. There was an announcement the other day of a new major shareholder. We know that there are big fish on the prowl. Keep in mind they try to accumulate around an average price until something tips the balance and they can no longer obtain shares at that price range anymore. Those buy sell algorithms going all day aren't your average discretionary trader.